Literature DB >> 22790874

Association of time-dependent changes in mu opioid receptor mRNA, but not BDNF, TrkB, or MeCP2 mRNA and protein expression in the rat nucleus accumbens with incubation of heroin craving.

Florence R M Theberge1, Charles L Pickens, Evan Goldart, Sanya Fanous, Bruce T Hope, Qing-Rong Liu, Yavin Shaham.   

Abstract

RATIONALE AND
OBJECTIVES: Responding to heroin cues progressively increases after cessation of heroin self-administration (incubation of heroin craving). We investigated whether this incubation is associated with time-dependent changes in brain-derived neurotrophic factor (BDNF) and methyl-CpG binding protein 2 (MeCP2) signaling and mu opioid receptor (MOR) expression in nucleus accumbens (NAc), dorsal striatum (DS), and medial prefrontal cortex (mPFC). We also investigated the effect of the preferential MOR antagonist naloxone on cue-induced heroin seeking during abstinence.
METHODS: We trained rats to self-administer heroin or saline for 9-10 days and then dissected the NAc, DS, and mPFC at different abstinence days and measured mRNA and protein levels of BDNF, TrkB, and MeCP2, as well as MOR mRNA (Oprm1). In other groups, we assessed cue-induced heroin seeking in extinction tests after 1, 11, and 30 abstinence days, and naloxone's (0-1.0 mg/kg) effect on extinction responding after 1 and 15 days.
RESULTS: Cue-induced heroin seeking progressively increased or incubated during abstinence. This incubation was not associated with changes in BDNF, TrkB, or MeCP2 mRNA or protein levels in NAc, DS, or mPFC; additionally, no molecular changes were observed after extinction tests on day 11. In NAc, but not DS or mPFC, MOR mRNA decreased on abstinence day 1 and returned to basal levels over time. Naloxone significantly decreased cue-induced heroin seeking after 15 abstinence days but not 1 day.
CONCLUSIONS: Results suggest a role of MOR in incubation of heroin craving. As previous studies implicated NAc BDNF in incubation of cocaine craving, our data suggest that different mechanisms contribute to incubation of heroin versus cocaine craving.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22790874      PMCID: PMC3593041          DOI: 10.1007/s00213-012-2784-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  67 in total

Review 1.  Drugs of abuse: anatomy, pharmacology and function of reward pathways.

Authors:  G F Koob
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

2.  Downregulation of mu-opioid receptor mRNA in the mediobasal hypothalamus of the female guinea pig following morphine treatment.

Authors:  O K Rønnekleiv; M A Bosch; M J Cunningham; E J Wagner; D K Grandy; M J Kelly
Journal:  Neurosci Lett       Date:  1996-09-27       Impact factor: 3.046

3.  Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain.

Authors:  M P Castelli; M Melis; M Mameli; P Fadda; G Diaz; G L Gessa
Journal:  Brain Res Mol Brain Res       Date:  1997-04

Review 4.  Neurobiology of the incubation of drug craving.

Authors:  Charles L Pickens; Mikko Airavaara; Florence Theberge; Sanya Fanous; Bruce T Hope; Yavin Shaham
Journal:  Trends Neurosci       Date:  2011-07-20       Impact factor: 13.837

5.  In vivo homologous regulation of mu-opioid receptor gene expression in the mouse.

Authors:  F Sehba; A Duttaroy; S Shah; B Chen; J Carroll; B C Yoburn
Journal:  Eur J Pharmacol       Date:  1997-11-19       Impact factor: 4.432

Review 6.  Opiate versus psychostimulant addiction: the differences do matter.

Authors:  Aldo Badiani; David Belin; David Epstein; Donna Calu; Yavin Shaham
Journal:  Nat Rev Neurosci       Date:  2011-10-05       Impact factor: 34.870

7.  Inhibition of PKMzeta in nucleus accumbens core abolishes long-term drug reward memory.

Authors:  Yan-qin Li; Yan-xue Xue; Ying-ying He; Fang-qiong Li; Li-fen Xue; Chun-mei Xu; Todd Charlton Sacktor; Yavin Shaham; Lin Lu
Journal:  J Neurosci       Date:  2011-04-06       Impact factor: 6.167

8.  Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist.

Authors:  B Buzas; J Rosenberger; B M Cox
Journal:  Neuroreport       Date:  1996-06-17       Impact factor: 1.837

Review 9.  p75 and Trk: a two-receptor system.

Authors:  M V Chao; B L Hempstead
Journal:  Trends Neurosci       Date:  1995-07       Impact factor: 13.837

10.  CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone.

Authors:  M Brodsky; K Elliott; A Hynansky; C E Inturrisi
Journal:  Brain Res Bull       Date:  1995       Impact factor: 4.077

View more
  28 in total

1.  Role of nucleus accumbens microRNA-181a and MeCP2 in incubation of heroin craving in male rats.

Authors:  Wenjin Xu; Qingxiao Hong; Zi Lin; Hong Ma; Weisheng Chen; Dingding Zhuang; Huaqiang Zhu; Miaojun Lai; Dan Fu; Wenhua Zhou; Huifen Liu
Journal:  Psychopharmacology (Berl)       Date:  2021-05-01       Impact factor: 4.530

Review 2.  Exercise as a novel treatment for drug addiction: a neurobiological and stage-dependent hypothesis.

Authors:  Wendy J Lynch; Alexis B Peterson; Victoria Sanchez; Jean Abel; Mark A Smith
Journal:  Neurosci Biobehav Rev       Date:  2013-06-24       Impact factor: 8.989

3.  Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice.

Authors:  Yong Zhang; Roberto Picetti; Eduardo R Butelman; Ann Ho; Julie A Blendy; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

4.  Brain-derived neurotrophic factor and addiction: Pathological versus therapeutic effects on drug seeking.

Authors:  Jacqueline M Barker; Jane R Taylor; Taco J De Vries; Jamie Peters
Journal:  Brain Res       Date:  2014-11-04       Impact factor: 3.252

Review 5.  Multiple faces of BDNF in cocaine addiction.

Authors:  Xuan Li; Marina E Wolf
Journal:  Behav Brain Res       Date:  2014-11-15       Impact factor: 3.332

6.  Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving.

Authors:  Florence R Theberge; Xuan Li; Sarita Kambhampati; Charles L Pickens; Robyn St Laurent; Jennifer M Bossert; Michael H Baumann; Mark R Hutchinson; Kenner C Rice; Linda R Watkins; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2013-02-04       Impact factor: 13.382

7.  Incubation of methamphetamine and palatable food craving after punishment-induced abstinence.

Authors:  Irina N Krasnova; Nathan J Marchant; Bruce Ladenheim; Michael T McCoy; Leigh V Panlilio; Jennifer M Bossert; Yavin Shaham; Jean L Cadet
Journal:  Neuropsychopharmacology       Date:  2014-03-03       Impact factor: 7.853

8.  MeCP2 regulates ethanol sensitivity and intake.

Authors:  Vez Repunte-Canonigo; Jihuan Chen; Celine Lefebvre; Tomoya Kawamura; Max Kreifeldt; Oan Basson; Amanda J Roberts; Pietro Paolo Sanna
Journal:  Addict Biol       Date:  2013-02-28       Impact factor: 4.280

Review 9.  The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research.

Authors:  Jennifer M Bossert; Nathan J Marchant; Donna J Calu; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2013-05-18       Impact factor: 4.530

10.  Adolescent oxycodone self administration alters subsequent oxycodone-induced conditioned place preference and anti-nociceptive effect in C57BL/6J mice in adulthood.

Authors:  Yong Zhang; Kyle Windisch; Joshua Altschuler; Sage Rahm; Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Neuropharmacology       Date:  2016-09-07       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.